Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This trial is conducted globally. The aim of this clinical trial is to investigate the safety
and pharmacokinetics (the determination of the concentration of the administered medication
in blood over time) of NNC 0129-0000-1003 in previously treated subjects with severe
haemophilia A.